Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review. Issue 9 (20th July 2022)

• Record Type: Journal Article
• Authors: Antoñanzas, Javier; Rodríguez‐Garijo, Nuria; Estenaga, Ángela; Morelló‐Vicente, Ana; España, Agustín; Aguado, Leyre
• Is Part Of: Dermatologic therapy. Volume 35:Issue 9(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-07-20
• Subjects: COVID -- cross‐reactivity -- immunorelated -- morphea -- vaccination; Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/dth.15709
• Languages: English
• ISSNs: 1396-0296

Abstract

Abstract: The appearance of morphea after vaccination has been reported to date as single and deep lesions that appear exactly at the site of the skin puncture. It was therefore postulated that the origin could be the trauma related to the injection. The aim of this article is to review the various hypotheses offered in the published literature about generalized morphea following vaccination. We present two cases of generalized morphea after COVID‐19 vaccination and review the published literature on immune‐related cutaneous reactions. As previously reported, antigenic cross‐reactivity between vaccine spike proteins and human tissues could cause certain immune‐mediated diseases, including generalized morphea. Herein we report two cases of generalized morphea probably induced by the COVID‐19 vaccine, given the temporal relationship with its administration. In summary, environmental factors such as vaccination against SARS‐COV‐2 could induce an immune system dysregulation, which would have an important role in the pathogenesis of morphea. We present two cases of generalized morphea probably induced by the COVID‐19 vaccine, given the time elapsed between vaccination and the onset of the skin lesions.